Drug intelligence / Profile preview

GM508 CultActive

Development stage
Unknown
Lead developer
Gynemed
Modality
Small Molecules
Administration
Parenteral
01

Overview

GM508 CultActive is a bicarbonate-buffered, human serum albumin (HSA)-free reagent designed for artificial oocyte activation (AOA) during assisted reproductive technology (ART) procedures, specifically intracytoplasmic sperm injection (ICSI). Developed by Gynemed, its active component is the calcium ionophore A23187 (also known as calcimycin). The reagent works by inducing a transient increase in intracellular calcium concentration within the oocyte, mimicking the physiological calcium oscillations normally triggered by a fertilizing sperm. This process is intended to rescue fertilization failure in cases of male factor infertility, such as globozoospermia or severe oligoasthenoteratozoospermia, where the sperm may be deficient in oocyte-activating factors. While used clinically in IVF procedures, it is often classified as a medical device or laboratory reagent rather than a traditional pharmaceutical.

Brand names
GM508 CultActiveGM-508 CultActiveGM 508 CultActive
Other names
CultActive

Beyond the preview

Go deeper on GM508 CultActive.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GM508 CultActive.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call